Grant RM - Search Results

1

The role of viral fitness in HIV pathogenesis.

Barbour JD, Grant RM. Barbour JD, et al. Among authors: grant rm. Curr HIV/AIDS Rep. 2005 Feb;2(1):29-34. doi: 10.1007/s11904-996-0006-1. Curr HIV/AIDS Rep. 2005. PMID: 16091246 Review.

2

Activation of virus replication after vaccination of HIV-1-infected individuals.

Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, Feinberg MB. Staprans SI, et al. Among authors: grant rm. J Exp Med. 1995 Dec 1;182(6):1727-37. doi: 10.1084/jem.182.6.1727. J Exp Med. 1995. PMID: 7500017 Free PMC article. Clinical Trial.

3

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, Heyes M, Aweeka F, Deeks S, Price RW. Staprans S, et al. Among authors: grant rm. AIDS. 1999 Jun 18;13(9):1051-61. doi: 10.1097/00002030-199906180-00008. AIDS. 1999. PMID: 10397535

4

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection.

Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM. Deeks SG, et al. Among authors: grant rm. J Infect Dis. 2000 Mar;181(3):946-53. doi: 10.1086/315334. J Infect Dis. 2000. PMID: 10720517

5

Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy.

Huang SS, Barbour JD, Deeks SG, Huang JS, Grant RM, Ng VL, McCune JM. Huang SS, et al. Among authors: grant rm. Clin Infect Dis. 2000 Mar;30(3):504-10. doi: 10.1086/313714. Clin Infect Dis. 2000. PMID: 10722435

6

Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1.

Schramm B, Penn ML, Palacios EH, Grant RM, Kirchhoff F, Goldsmith MA. Schramm B, et al. Among authors: grant rm. J Virol. 2000 Oct;74(20):9594-600. doi: 10.1128/jvi.74.20.9594-9600.2000. J Virol. 2000. PMID: 11000231 Free PMC article.

7

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK, Grant RM. Deeks SG, et al. Among authors: grant rm. N Engl J Med. 2001 Feb 15;344(7):472-80. doi: 10.1056/NEJM200102153440702. N Engl J Med. 2001. PMID: 11172188 Free article. Clinical Trial.

8

Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues.

Penn ML, Myers M, Eckstein DA, Liegler TJ, Hayden M, Mammano F, Clavel F, Deeks SG, Grant RM, Goldsmith MA. Penn ML, et al. Among authors: grant rm. AIDS Res Hum Retroviruses. 2001 Apr 10;17(6):517-23. doi: 10.1089/08892220151126580. AIDS Res Hum Retroviruses. 2001. PMID: 11350665

9

Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.

Stoddart CA, Liegler TJ, Mammano F, Linquist-Stepps VD, Hayden MS, Deeks SG, Grant RM, Clavel F, McCune JM. Stoddart CA, et al. Among authors: grant rm. Nat Med. 2001 Jun;7(6):712-8. doi: 10.1038/89090. Nat Med. 2001. PMID: 11385509

10

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.

Deeks SG, Barbour JD, Grant RM, Martin JN. Deeks SG, et al. Among authors: grant rm. AIDS. 2002 Jan 25;16(2):201-7. doi: 10.1097/00002030-200201250-00009. AIDS. 2002. PMID: 11807304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters